{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v2.0/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Verapamil",
            "Path": "C:/Projects/Github/Verapamil/Verapamil.json",
            "BuildingBlocks": [],
            "SimulationParameters": []
        }
    ],
    "ObservedDataSets": [],
    "Plots": {
        "AxesSettings": {
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "ComparisonTimeProfile": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "PKRatioPlots": [
                {
                    "Type": "X",
                    "Dimension": "Age",
                    "Unit": "year(s)",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AllPlots": [
            {
                "Project": "Verapamil",
                "Simulation": "Barbarash 1988 + McAllister 1982 (10 mg IV SD)",
                "SectionId": 331
            },
            {
                "Project": "Verapamil",
                "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
                "SectionId": 331
            },
            {
                "Project": "Verapamil",
                "Simulation": "Johnston 1981 (0.1 mg/kg IV SD)",
                "SectionId": 332
            },
            {
                "Project": "Verapamil",
                "Simulation": "Streit 2005 (5 mg IV SD)",
                "SectionId": 332
            },
            {
                "Project": "Verapamil",
                "Simulation": "Maeda 2011 (0.1 mg PO SD)",
                "SectionId": 332
            },
            {
                "Project": "Verapamil",
                "Simulation": "Maeda 2011 (16 mg PO SD)",
                "SectionId": 332
            },
            {
                "Project": "Verapamil",
                "Simulation": "Maeda 2011 (80 mg PO SD)",
                "SectionId": 332
            },
            {
                "Project": "Verapamil",
                "Simulation": "Johnson 2001 (80 mg PO TID)",
                "SectionId": 332
            },
            {
                "Project": "Verapamil",
                "Simulation": "Hla 1987 (120 mg PO BID)",
                "SectionId": 332
            },
            {
                "Project": "Verapamil",
                "Simulation": "Jorgensen 1988 (120 mg PO BID)",
                "SectionId": 332
            },
            {
                "Project": "Verapamil",
                "Simulation": "Shand 1981 (120 mg PO TID)",
                "SectionId": 332
            },
            {
                "Project": "Verapamil",
                "Simulation": "Karim 1995 (240 mg PO SD controlled release)",
                "SectionId": 332
            }
        ],
        "GOFMergedPlots": [
            {
                "Title": "Goodness of fit plor for concentration in plasma",
                "SectionId": 32,
                "Artifacts": [
                    "Plot",
                    "GMFE",
                    "Measure"
                ],
                "PlotType": "predictedVsObserved|residualsOverTime",
                "Groups": [
                    {
                        "Caption": "IV administration",
                        "Symbol": "Square",
                        "OutputMappings": [
                            {
                                "Project": "Verapamil",
                                "Simulation": "Barbarash 1988 + McAllister 1982 (10 mg IV SD)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "McAllister 1982 - Verapamil 10 mg IV - Verapamil - IV - 10 mg - Plasma - agg. (n=20)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Barbarash 1988 + McAllister 1982 (10 mg IV SD)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Barbarash 1988 - Verapamil IV control - Verapamil - IV - 10 mg - Serum - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Johnston 1981 (0.1 mg/kg IV SD)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Johnston 1981 - Verapamil IV - Verapamil - IV - 0.1 mg/kg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Streit 2005 (5 mg IV SD)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Streit 2005 - intravenous verapamil during normoxia (5 mg) - Verapamil - IV - 5 mg - Plasma - agg. (n=10)",
                                "Color": "#FF0000"
                            }
                        ]
                    },
                    {
                        "Caption": "PO administration",
                        "Symbol": "Circle",
                        "OutputMappings": [
                            {
                                "Project": "Verapamil",
                                "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Johnston 1981 - Verapamil PO - Verapamil - PO - 120 mg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "McAllister 1982 - Verapamil 120 mg PO - Verapamil - PO - 120 mg - Plasma - agg. (n=20)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Hla 1987 - conventional Verapamil 120mg once daily (day 1) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Barbarash 1988 - Verapamil PO control - Verapamil - PO - 120 mg - Serum - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Maeda 2011 (80 mg PO SD)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Maeda 2011 - Verapamil 80 mg - Verapamil - PO - 80 mg - Plasma - agg. (n=8)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Hla 1987 (120 mg PO BID)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Hla 1987 - conventional Verapamil 120mg twice daily (day 10) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Jorgensen 1988 (120 mg PO BID)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Shand 1981 (120 mg PO TID)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Shand 1981 - Verapamil day 1 - Verapamil - PO - 120 mg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Shand 1981 (120 mg PO TID)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Shand 1981 - Verapamil day 3 (after 7th dose) - Verapamil - PO - 120 mg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Karim 1995 (240 mg PO SD controlled release)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Karim 1995 - Verapamil total IR fasting - Verapamil - PO - 240 mg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Maeda 2011 (16 mg PO SD)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Maeda 2011 - Verapamil 16 mg - Verapamil - PO - 16 mg - Plasma - agg. (n=8)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Maeda 2011 (0.1 mg PO SD)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Maeda 2011 - Verapamil 100 Âµg - Verapamil - PO - 0.1 mg - Plasma - agg. (n=8)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Verapamil",
                                "Simulation": "Johnson 2001 (80 mg PO TID)",
                                "Output": "Organism|PeripheralVenousBlood|Verapamil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Johnson 2001 - Verapamil Steady State - Verapamil - PO - 80 mg - Plasma - agg. (n=12)",
                                "Color": "#FF0000"
                            }
                        ]
                    }
                ]
            }
        ],
        "ComparisonTimeProfilePlots": [],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [
        {
            "Project": "Verapamil",
            "Name": "Verapamil",
            "Type": "Compound",
            "SectionId": 31
        },
        {
            "Project": "Verapamil",
            "Name": "solution",
            "Type": "Formulation",
            "SectionId": 31
        },
        {
            "Project": "Verapamil",
            "Name": "controlled release",
            "Type": "Formulation",
            "SectionId": 31
        }
    ],
    "Sections": [
        {
            "Id": 1,
            "Title": "1 Introduction",
            "Content": "Content/Section1_Introduction.md"
        },
        {
            "Id": 2,
            "Title": "2 Methods",
            "Content": "Content/Section2_Methods.md",
            "Sections": [
                {
                    "Id": 21,
                    "Title": "2.1 Modeling Strategy",
                    "Content": "Content/Section2.1_Modeling_Strategy.md"
                },
                {
                    "Id": 22,
                    "Title": "2.2 Data",
                    "Content": "Content/Section2.2_Data.md"
                },
                {
                    "Id": 23,
                    "Title": "2.3 Model Parameters and Assumptions",
                    "Content": "Content/Section2.3_Model_Parameters_and_Assumptions.md"
                }
            ]
        },
        {
            "Id": 3,
            "Title": "3 Results and Discussion",
            "Content": "Content/Section3_Results_and_Discussion.md",
            "Sections": [
                {
                    "Id": 31,
                    "Title": "3.1 Final input parameters",
                    "Content": "Content/Input_table.md"
                },
                {
                    "Id": 32,
                    "Title": "3.2 Diagnostics Plots",
                    "Content": "Content/GOF_diagnostics.md"
                },
                {
                    "Id": 33,
                    "Title": "3.3: Concentration-Time Profiles",
                    "Content": "Content/Concentration_time_profiles.md",
                    "Sections": [
                        {
                            "Id": 331,
                            "Title": "3.3.1 Model Building",
                            "Content": "Content/Concentration_time_profiles_building.md"
                        },
                        {
                            "Id": 332,
                            "Title": "3.3.2 Model verification",
                            "Content": "Content/Concentration_time_profiles_verification.md"
                        }
                    ]
                }
            ]
        },
        {
            "Id": 4,
            "Title": "4 Conclusion",
            "Content": "Content/Section4_Conclusion.md"
        },
        {
            "Id": 5,
            "Title": "5 References",
            "Content": "Content/References.md"
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
        }
    ]
}